CLDX - Celldex TherapeuticsAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $17.98 | Open | $17.88 |
| Volume | 438.3K | Market Cap | 711.42M |
| Yield | Last Dividend |
| Celldex Doses First Patient in Phase 1b ... | 12/09/20 |
| HAMPTON, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the first patient has been dosed in its... | |
| The Daily Biotech Pulse: Revance's DAXI ... | 11/25/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24) Abb... | |
| Celldex Therapeutics (NASDAQ:CLDX) Given... | 11/20/20 |
| Lifesci Capital reiterated their outperform rating on shares of Celldex Therapeutics (NASDAQ:CLDX) in a report published on Tuesday morning, Zacks.com... | |
| The Daily Biotech Pulse: Urovant In M&A ... | 11/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 12) ALX... | |
| The Week Ahead In Biotech: Supernus, San... | 11/08/20 |
| Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a change of gua... | |
| Celldex Provides Corporate Update and Re... | 11/05/20 |
| HAMPTON, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the thi... | |
| Personalized Cancer Vaccines Market (COV... | 10/27/20 |
| This Personalized Cancer Vaccines Market research report makes available state-of-the-art information about the entire market along with the holistic ... | |
| HC Wainwright Raises Celldex Therapeutic... | 10/21/20 |
| Celldex Therapeutics (NASDAQ:CLDX) had its price target upped by HC Wainwright from $16.00 to $25.00 in a research note published on Monday, The Fly r... | |
| Celldex Therapeutics (NASDAQ:CLDX) Price... | 10/19/20 |
| Celldex Therapeutics (NASDAQ:CLDX) had its price target upped by HC Wainwright from $16.00 to $25.00 in a report released on Monday, The Fly reports. ... | |
| Antibody Drug Conjugate Market, Top key ... | 10/12/20 |
| Antibody Drug Conjugate Market Size, Status and Forecast 2026 The Antibody Drug Conjugate Market Research Report is a valuable source of insightful da... | |
| The Daily Biotech Pulse: Gilead, Lilly C... | 10/08/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs Oct. 7) 10X ... | |
| The Daily Biotech Pulse: Bristol-Myers S... | 10/07/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X ... | |
| The Daily Biotech Pulse: Pfizer, BioNTec... | 10/06/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X ... | |
| The Daily Biotech Pulse: Eton Snags Seco... | 09/30/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Ac... | |
| The Daily Biotech Pulse: FDA Nod For Pfi... | 09/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28) 10... | |
| Celldex Therapeutics to Present at Upcom... | 09/10/20 |
| HAMPTON, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that the Company will participate in Firesi... | |
| Celldex Provides Corporate Update and Re... | 08/06/20 |
| --Conference Call and Webcast today at 4:30pm ET-- | |
| Celldex to Report Second Quarter 2020 Fi... | 08/03/20 |
| HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on Thursda... | |
| Celldex Therapeutics Announces Pricing o... | 06/15/20 |
| HAMPTON, N.J., June 15, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (???Celldex??? or the ???Company???) (Nasdaq: CLDX), today announced the p... | |
| Is Celldex Therapeutics, Inc. (CLDX) Sto... | 05/06/20 |
| Is (CLDX) Outperforming Other Medical Stocks This Year? | |
| Celldex Announces Acceptance of CDX-0159... | 05/06/20 |
| HAMPTON, N.J., May 06, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that results from the Phase 1 study of CDX-01... | |
| Celldex (CLDX) Soars: Stock Adds 10% in ... | 04/24/20 |
| Celldex (CLDX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes. | |
| The Daily Biotech Pulse: Mylan Ramps Up ... | 03/20/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) ... | |
| The Daily Biotech Pulse: Pfizer's Eczema... | 03/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)... | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| Celldex (CLDX) Down 3.9% Since Last Earn... | 12/12/19 |
| Celldex (CLDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Celldex Initiates Phase 1 Study of KIT I... | 11/18/19 |
| Celldex Therapeutics, Inc. (CLDX) announced today that a Phase 1a study of CDX-0159 has initiated in healthy volunteers. CDX-0159 is a humanized monoc... | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 11/03/19 |
| Biotech stocks extended their gains last week amid earnings news flow and the broader market strength. Large-cap pharma stocks saw particular strength... | |
| Will Celldex Therapeutics (CLDX) Report ... | 10/30/19 |
| Celldex (CLDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| Celldex Therapeutics to Present at the C... | 09/30/19 |
| HAMPTON, N.J., Sept. 30, 2019 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony Marucci, Co-founder, President and Chief Execut... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 66.00 % | Follow |
| LavaPit | Steve Pitkin | 57.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
